EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence

Is This Study For You?

Let's Get Started!




Highlands Ranch Hospital
Lone Tree Medical Center
University of Colorado Hospital

Principal Investigator
Photograph of Elena Shagisultanova

Elena Shagisultanova

Study ID

Protocol Number: 22-1554

More information available at ClinicalTrials.gov: NCT05514054

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers